SYDNEY, Australia, 8th of December 2022 – Complementary Medicines Australia (CMA) announced TSI Group, the winner of the CMA’s prestigious 2022 High Quality Manufacturer of the Year at the 23rd annual CMA Industry Awards. This award honors the manufacturer of the year and celebrates the company that has made the most significant contribution to the complementary medicines industry throughout the past year.
“As a manufacturer of ingredients and finished products, as well as a partner for some of Australia’s leading brands, we as a team are delighted and proud to have received this award.” said Patrick Antolak, Sales & Marketing Executive ANZ, TSI Group.”
Winning this award signifies TSI’s commitment to and production of the highest standard products and represents the complementary medicines industry to the highest standard.
“Every staff at TSI Group plays a crucial role in our success, from those who work on the production line to those in technical services, finance, and customer support.” said Lin Zheng, General Manager ANZ, TSI Group. “Thanks to the CMA, we should all be proud of the fact that our industry in Australia is acknowledged for the excellence of our products and the high standards of raw materials sourced to produce quality complementary medicines”.
About TSI Group
TSI Group is comprised of three divisions working together with one goal to create value for our brand partners and their customers. Within the Ingredient Solutions, Innovative Products, and Contract Manufacturing divisions, we have teams of researchers, scientists, regulatory specialists, and product development experts each working in tandem to help create solutions for improving health.
About Complementary Medicines Australia
Complementary Medicines Australia (CMA) is the peak industry body for the Australian complementary medicines industry, representing members across the supply chain, including manufacturers, importers, exporters, raw material suppliers, wholesalers, distributors, and retailers. CMA promotes appropriate industry regulation and advancement to ensure consumers have access to complementary medicines of the highest quality.